- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Everolimus (RAD001)
Total 1058 results
-
GERCOR - Multidisciplinary Oncology Cooperative...Completed
-
Herbert Hurwitz, MDNovartis; Genentech, Inc.; AmgenCompleted
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); NovartisActive, not recruitingRefractory Hurthle Cell Thyroid CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedLiver Metastases | Gastrinoma | Glucagonoma | Insulinoma | Pancreatic Polypeptide Tumor | Recurrent Islet Cell Carcinoma | SomatostatinomaUnited States
-
Duke UniversityNovartis; PfizerCompletedAdvanced Non-clear Cell Renal Cell CarcinomaUnited States, Canada, United Kingdom
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBayer; NovartisCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Triple-negative Breast Carcinoma | Progesterone Receptor-negativeUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
Dana-Farber Cancer InstituteNovartis; Millennium Pharmaceuticals, Inc.TerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Swiss Group for Clinical Cancer ResearchTerminated
-
Novartis PharmaceuticalsCompletedRenal TransplantationSwitzerland
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerFrance, Canada, United States, Russian Federation, Denmark
-
M.D. Anderson Cancer CenterNovartisCompleted
-
University of California, San FranciscoNovartisCompleted
-
Washington University School of MedicineTyrogenexTerminatedAdenocarcinoma | Pancreatic NeoplasmsUnited States
-
Novartis PharmaceuticalsCompletedCarcinoid Tumor | Malignant Carcinoid SyndromeFrance, Spain, Netherlands, United States, Canada, Sweden, Italy, Australia, Germany, Greece, Belgium, Czech Republic, Slovakia, Finland, United Kingdom
-
M.D. Anderson Cancer CenterCompleted
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.TerminatedIntracranial MeningiomaUnited States
-
University of California, San FranciscoGenentech, Inc.; Novartis Pharmaceuticals; The V Foundation for Cancer ResearchTerminated
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedHEAD & NECK CancerUnited States
-
Novartis PharmaceuticalsCompletedLiver Transplant RecipientBelgium, Spain, Germany, Italy, Australia, United States, Netherlands, Ireland, Sweden, Brazil, Colombia, France, Russian Federation, Argentina, Czechia, United Kingdom
-
Federico II UniversityCompletedMedullary Thyroid CancerItaly
-
Herbert HurwitzGenentech, Inc.; Novartis PharmaceuticalsCompletedColorectal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedPancreatic Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Emory UniversityTerminated
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
University of Southern CaliforniaNovartis; Genentech, Inc.CompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
University of UtahNovartisCompleted
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia | Myelofibrosis | Mantle Cell LymphomaUnited States
-
University of California, San FranciscoNovartisTerminatedLow Grade Glioma | World Health Organization (WHO) Grade II Astrocytomas | Oligodendrogliomas | Mixed OligoastrocytomasUnited States
-
The Methodist Hospital Research InstituteNovartis PharmaceuticalsCompletedCarcinoma, Renal CellUnited States
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Asan Medical CenterCompletedAdvanced Gastric CancerKorea, Republic of
-
University of California, DavisNovartisCompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.Completed
-
Sandy SrinivasNovartis; Genentech, Inc.TerminatedKidney Neoplasms | Kidney (Renal Cell) CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Yale UniversityNovartisCompletedEndometrial CancerUnited States
-
M.D. Anderson Cancer CenterNovartis; Genentech, Inc.CompletedNeuroendocrine CarcinomaUnited States
-
Milton S. Hershey Medical CenterWithdrawnMultiple MyelomaUnited States